Novel contrast-enhanced ultrasound imaging in prostate cancer - Takeaways - MDSpire

Novel contrast-enhanced ultrasound imaging in prostate cancer

  • By

  • Martijn Smeenge

  • Massimo Mischi

  • M. Pilar Laguna Pes

  • Jean J. M. C. H. de la Rosette

  • Hessel Wijkstra

  • August 17, 2011

  • 0 min

Share

  • 1

    Prostate cancer is the most common neoplasm in men, with rising incidence rates, particularly in older populations.

  • 2

    Standard grayscale transrectal ultrasound (TRUS) has low accuracy for diagnosing prostate cancer, detecting only 11-35% of malignancies.

  • 3

    Computerized transrectal ultrasound (C-TRUS) significantly improved cancer detection rates, identifying 50% of cancers in patients with previous negative biopsies.

  • 4

    Contrast-enhanced ultrasound (CEUS) enhances sensitivity for detecting prostate cancer by visualizing blood flow changes in malignant tissue.

  • 5

    Current ultrasound contrast agents consist of gas-filled microbubbles, improving detection of low blood flow in prostate cancer's microvasculature.

Original Source(s)

Novel contrast-enhanced ultrasound imaging in prostate cancer

  • by Martijn Smeenge, Massimo Mischi, M. Pilar Laguna Pes, Jean J. M. C. H. de la Rosette, Hessel Wijkstra

  • August 17, 2011

Related Content

Grading urothelial carcinoma with probe-based confocal laser endomicroscopy during flexible cystoscopy

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

Sharper Imaging, Smarter Tools: Inside the MonacoPro

With its combination of UWF imaging, OCT integration, and intelligent review tools, the MonacoPro represents the next step in comprehensive retinal evaluation. By improving image quality, enhancing diagnostic confidence, and streamlining workflow, the system supports clinicians in delivering more efficient, informed, and patient-centered care.